Indeed, in another study of patients receiving a range of different first-line treatments, those achieving EFS12 showed a trend towards lower mortality than age- and sex-matched controls, with an SMR of 0.73 (95% confidence interval 0.56–0.94) [ 19 ].
← all excerpts
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.
1
—
—